Medical Imaging-based AI solutions are accelerating and improving drug development pipelines and enabling personalized healthcare. Development of these solutions requires a unified, agile, secure, and collaborative framework spanning the entire AI lifecycle. To streamline and enhance this process, Novartis is leveraging the Flywheel AI Factory, augmented by NVIDIA MONAI (Medical Open Network for Artificial Intelligence) for data ingestion and curation, annotation and labeling, model training and validation and inference. By incorporating NVIDIA's robust capabilities into Flywheel Core, Novartis achieves unparalleled efficiency, flexibility, and reproducibility throughout the entire AI development lifecycle.
Watch to learn how this cohesive environment accelerates the conversion of complex imaging data into analysis-ready datasets while ensuring regulatory compliance through version control and provenance tracking. Such achievements highlight powerful Flywheel and NVIDIA synergies, propelling medical imaging research, boosting efficiencies, and spearheading trustworthy AI, on the path to deploying AI solutions at trial sites (for screening) and CROs (for secondary analyses).
See the recording from NVIDIA on-demand.
